ARS Pharmaceuticals (SPRY)

• Market cap: $885M
• 1 day: 3.94%
• 5 days: -2.71%
• 1 month: -10.85%
• 3 months: -49.32%
• 6 months: -35.86%
• Year to date: -16.34%
• 1 year: -39.13%
• 5 years: -64.16%
• 10 years: -64.16%
• Sector: Healthcare
• Industry: Biotechnology

About: ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Employees: 167